How Worried Should Investors Be About Exscientia Plc ADR (EXAI)

Exscientia Plc ADR (NASDAQ:EXAI) does about 751.24K shares in volume on a normal day but saw 630144 shares change hands in Friday trading. The company now has a market cap of 587.02M USD. Its current market price is $4.67, marking a decrease of -8.25% compared to the previous close of $5.09. The 52 week high reached by this stock is $9.12 whilst the lowest price level in 52 weeks is $3.86.

Exscientia Plc ADR (EXAI) has a 20-day trading average at $4.55 and the current price is -48.79% off the 52-week high compared with 20.98% distance from its 52-week low. The 50-day simple moving average of the closing price is $5.42 and its 200-day simple moving average is $5.89. If we look at the stock’s price movements over the week, volatility stands at 10.97%, which decreases to 6.96% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 46.74 to suggest the stock is neutral.

The consensus objective for the share price is $8.67, suggesting that the stock has a potential upside of 46.14% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on January 05, 2024 when BofA Securities downgraded the stock to “Neutral” and issued a price target of between $11 and $9.

Exscientia Plc ADR (EXAI) stock is up 15.88% over the week and -6.04% over the past month. Its price is -27.15% year-to-date and -8.25% over the past year.

The stock last released its quarterly earnings report for quarter ended 12/31/2023, with the company’s earnings per share (EPS) of -0.38 below consensus estimates by -0.03. The company’s next earnings report forecasts estimating quarterly EPS at -0.37 and -1.37 for whole year. Expected sales for next quarter are $15.01M, which analysts say will come at $57.76M for the current fiscal year and next year at $31.18M. In addition, estimates put the company’s current quarterly revenue at an average of $7.5M.

To reach the target analysts have set, the stock logically needs to grow 46.14 percent from here.

The company has a return on investment of -38.20% and return on equity of -35.22%. The beta has a value of 0.82. Price to book ratio is 1.29 and price to sales ratio is 23.46.